CSI Market
Sign In | Register

Bausch Health Companies Inc (BHC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BHC quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Bausch Health Companies Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income157.00
Depreciation & amortization207.00
Amortization of Other Assets94.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges145.00
Provision For Loan Losses Expensed10.00
Increase (Decrease) in Inventories12.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total6.00
Share-based Compensation216.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-52.00
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset-
Allowances For Losses On Accounts Receivable And Inventories71.00
Deferred Income Tax Noncash Expense Benefit80.00
Non Cash Cost Alliance Revenue-
Gain Loss Related To Litigation Settlement-
Payment Of Accreted Interest On Repurchase Of Convertible Debt-
Employee Service Share Based Compensation Tax Benefit From Compensation Expense-
Acquisition Accounting Adjustment On Inventory Sold-
Derivative Gain Excluded Component-10.00
Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities-
Payment For Contingent Consideration Liability Including Accretion Operating Activities-8.00
Gain Loss Related To Litigation Settlement Gross61.00
Foreign Currency Transaction And Other Gain Loss Before Tax-11.00
Income taxes132.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable134.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-76.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net-37.00
Payments for (Proceeds from) Other Operating Activities-42.00
Discontinued operations0.00
Net Cash flow from Operating Activities1,400.00
Investing Activities
Capital Expenditures10.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities8.00
Payments to Acquire Marketable Securities11.00
Payments for (Proceeds from) Hedge, Investing Activities-12.00
Interest Settlement On Cross Currency Swaps-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested7.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-204.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-595.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions45.00
Long-term debt - borrowings10,554.00
Long-term debt - repayments11,191.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net24.00
Other net-1,277.00
Payments Of Contingent Consideration-
Settlement Of Convertible Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1,201.00
Payment Of Deferred Consideration-
Restricted Cash Current16.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Other Settlement Deposits-
Restricted Cash And Other Settlement Deposits Current-
Proceeds From Issuance Initial Public Offering Net Of Costs Related Party-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-742.00
Effect of exchange rate on cash flow61.00
Discontinued operations0.00
Free Cash Flow1,410.00
Total Cash Flow124.00
4 historic quarters locked

Sign in to unlock the full Bausch Health Companies Inc cash flow history.

Sign In Create Free Account

About Bausch Health Companies Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 18, 2026
  • Source: bhc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000885590-26-000023

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License